Laura Rodriguez de la Ballina

Laura Rodriguez de la Ballina

Auto-generated profile, based on publicly available information

Laura Rodriguez de la Ballina

Faculty of Medicine Centre for Cancer Cell Reprogramming Institute of Clinical Medicine University of Oslo Montebello Oslo Norway

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
Alf Håkon LystadAlf Håkon Lystad
Alf Håkon Lystad
SCSven R. Carlsson
Sven R. Carlsson
LBLaura R. de la Ballina
Laura R. de la Ballina
KKKarlina J. Kauffman
Karlina J. Kauffman
SNShanta Nag
Shanta Nag
ASAnne Simonsen
Anne Simonsen

31 July 2016 in Cancer Research
Verified
Journal Article
Open access
PDF file
YCYann Cormerais
Yann Cormerais
SGSandy Giuliano
Sandy Giuliano
RLRenaud LeFloch
Renaud LeFloch
BFBenoît Front
Benoît Front
JDJerome Durivault
Jerome Durivault
JPJacques Pouyssegur
Jacques Pouyssegur
The CD98/LAT1 complex is overexpressed in aggressive human cancers and is thereby described as a potential therapeutic target. This complex promotes tumorigenesis with CD98 (4F2hc) engaging β-integrin signaling while LAT1 (SLC7A5) imports essential amino acids (EAA) and promotes mTORC1 activity. However, it is unclear as to which member of the heterodimer carries the most prevalent protumoral action. To answer this question, we explored the tumoral potential of each member by gene disruption of CD98, LAT1, or both and by inhibition of LAT1 with the selective inhibitor (JPH203) in six human cancer cell lines from colon, lung, and kidney. Each knockout respectively ablated 90% (CD98KO) and 100% (LAT1KO) of Na+-independent leucine transport activity. LAT1KO or JPH203-treated cells presented an amino acid stress response with ATF4, GCN2 activation, mTORC1 inhibition, and severe in vitro and in vivo tumor growth arrest. We show that this severe growth phenotype is independent of the level of expression of CD98 in the six tumor cell lines. Surprisingly, CD98KO cells with only 10% EAA transport activity displayed a normal growth phenotype, with mTORC1 activity and tumor growth rate undistinguishable from wild-type cells. However, CD98KO cells became extremely sensitive to inhibition or genetic disruption of LAT1 (CD98KO/LAT1KO). This finding demonstrates that the tumoral potential of CD98KO cells is due to residual LAT1 transport activity. Therefore, these findings clearly establish that LAT1 transport activity is the key growth-limiting step of the heterodimer and advocate the pharmacology development of LAT1 transporter inhibitors as a very promising anticancer target. Cancer Res; 76(15); 4481–92. ©2016 AACR.

18 November 2004 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
VMVéronique Masson
Véronique Masson
LBLaura Rodriguez De La Ballina
Laura Rodriguez De La Ballina
CMCarine Munaut
Carine Munaut
Ben WielockxBen Wielockx
Ben Wielockx
MJMaud Jost
Maud Jost
ANAgnes Noel
Agnes Noel
The matrix metalloproteinases (MMPs) play a key role in normal and pathological angiogenesis by mediating extracellular matrix degradation and/or controlling the biological activity of growth factors, chemokines, and/or cytokines. Specific functions of individual MMPs as anti‐ or proangiogenic mediators remain to be elucidated. In the present study, we assessed the impact of single or combined MMP deficiencies in in vivo and in vitro models of angiogenesis (malignant keratinocyte transplantation and the aortic ring assay, respectively). MMP‐9 was predominantly expressed by neutrophils in tumor transplants, whereas MMP‐2 and MMP‐3 were stromal. Neither the single deficiency of MMP‐2, MMP‐3, or MMP‐9, nor the combined absence of MMP‐9 and MMP‐3 did impair tumor invasion and vascularization in vivo. However, there was a striking cooperative effect in double MMP‐2:MMP‐9‐deficient mice as demonstrated by the absence of tumor vascularization and invasion. In contrast, the combined lack of MMP‐2 and MMP‐9 did not impair the in vitro capillary outgrowth from aortic rings. These results point to the importance of a cross talk between several host cells for the in vivo tumor promoting and angiogenic effects of MMP‐2 and MMP‐9. Our data demonstrate for the first time in an experimental model that MMP‐2 and MMP‐9 cooperate in promoting the in vivo invasive and angiogenic phenotype of malignant keratinocytes.

1 October 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Joana FortJoana Fort
Joana Fort
LBLaura R. de la Ballina
Laura R. de la Ballina
HBHans E. Burghardt
Hans E. Burghardt
CFCarles Ferrer-Costa
Carles Ferrer-Costa
JTJavier Turnay
Javier Turnay
MPManuel Palacín
Manuel Palacín
4F2hc (CD98hc) is a multifunctional type II membrane glycoprotein involved in amino acid transport and cell fusion, adhesion, and transformation. The structure of the ectodomain of human 4F2hc has been solved using monoclinic (Protein Data Bank code 2DH2) and orthorhombic (Protein Data Bank code 2DH3) crystal forms at 2.1 and 2.8 Å, respectively. It is composed of a (βα)8 barrel and an antiparallel β8 sandwich related to bacterial α-glycosidases, although lacking key catalytic residues and consequently catalytic activity. 2DH3 is a dimer with Zn2+ coordination at the interface. Human 4F2hc expressed in several cell types resulted in cell surface and Cys109 disulfide bridge-linked homodimers with major architectural features of the crystal dimer, as demonstrated by cross-linking experiments. 4F2hc has no significant hydrophobic patches at the surface. Monomer and homodimer have a polarized charged surface. The N terminus of the solved structure, including the position of Cys109 residue located four residues apart from the transmembrane domain, is adjacent to the positive face of the ectodomain. This location of the N terminus and the Cys109-intervening disulfide bridge imposes space restrictions sufficient to support a model for electrostatic interaction of the 4F2hc ectodomain with membrane phospholipids. These results provide the first crystal structure of heteromeric amino acid transporters and suggest a dynamic interaction of the 4F2hc ectodomain with the plasma membrane.

20 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMichael J. Munson
Michael J. Munson
BMBenan J. Mathai
Benan J. Mathai
MNMatthew Yoke Wui Ng
Matthew Yoke Wui Ng
LTLaura Trachsel-Moncho
Laura Trachsel-Moncho
LBLaura R. de la Ballina
Laura R. de la Ballina
ASAnne Simonsen
Anne Simonsen
The mechanisms involved in programmed or damage-induced removal of mitochondria by mitophagy remains elusive. Here, we have screened for regulators of PRKN-independent mitophagy using an siRNA library targeting 197 proteins containing lipid interacting domains. We identify Cyclin G-associated kinase (GAK) and Protein Kinase C Delta (PRKCD) as regulators of PRKN-independent mitophagy, with both being dispensable for PRKN-dependent mitophagy and starvation-induced autophagy. We demonstrate that the kinase activity of both GAK and PRKCD are required for efficient mitophagy in vitro, that PRKCD is present on mitochondria, and that PRKCD facilitates recruitment of ULK1/ATG13 to early autophagic structures. Importantly, we demonstrate in vivo relevance for both kinases in the regulation of basal mitophagy. Knockdown of GAK homologue (gakh-1) in C. elegans or knockout of PRKCD homologues in zebrafish led to significant inhibition of basal mitophagy, highlighting the evolutionary relevance of these kinases in mitophagy regulation.

13 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SHSøs Grønbæk Holdgaard
Søs Grønbæk Holdgaard
VCValentina Cianfanelli
Valentina Cianfanelli
EPEmanuela Pupo
Emanuela Pupo
MLMatteo Lambrughi
Matteo Lambrughi
MLMichal Lubas
Michal Lubas
FCFrancesco Cecconi
Francesco Cecconi
The centrosome is the master orchestrator of mitotic spindle formation and chromosome segregation in animal cells. Centrosome abnormalities are frequently observed in cancer, but little is known of their origin and about pathways affecting centrosome homeostasis. Here we show that autophagy preserves centrosome organization and stability through selective turnover of centriolar satellite components, a process we termed doryphagy. Autophagy targets the satellite organizer PCM1 by interacting with GABARAPs via a C-terminal LIR motif. Accordingly, autophagy deficiency results in accumulation of large abnormal centriolar satellites and a resultant dysregulation of centrosome composition. These alterations have critical impact on centrosome stability and lead to mitotic centrosome fragmentation and unbalanced chromosome segregation. Our findings identify doryphagy as an important centrosome-regulating pathway and bring mechanistic insights to the link between autophagy dysfunction and chromosomal instability. In addition, we highlight the vital role of centriolar satellites in maintaining centrosome integrity.